May 15, 2026

Does Micro-CT Accurately Reconstruct Fragmented Teeth in Forensics?

Researchers achieved sub-100-µm precision when digitally reassociating fragmented teeth in a controlled forensic model.

Conexiant

May 15, 2026

First Patient Treated with Proton Therapy at Lynn Cancer Institute

The Eugene M. & Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital, part of Baptist Health, reached an important milestone in the advancement of cancer care with the successful treatment of its first patient utilizing proton therapy, according to physicians at both the Institute and the hospital.

Baptist Health South Florida

May 15, 2026

Non-Invasive Techniques In Pediatric Dyslipidemia

Damon B. Dixon, MD, at Phoenix Children’s Cardiology, is the author to this EndoText chapter. Dr. Dixon brings nationally recognized expertise in pediatric cardiovascular risk assessment and non?invasive vascular imaging.

Phoenix Children's Medical Connection

May 15, 2026

FDA Approves Atezolizumab for Adjuvant Treatment of MRD-Positive Muscle-Invasive Bladder Cancer

Today, the FDA approved the PD-L1 inhbitor atezolizumab (Tecentriq) and atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza) as adjuvant therapies for adults with muscle-invasive bladder cancer aft...

The ASCO Post

May 15, 2026

Sigmoidoscopy Reduces CRC Incidence Rates in Men in Norwegian Screening Study

Offering sigmoidoscopy screening led to reduced incidence of colorectal cancer, though more for men vs women, and a reduced rate of colorectal cancer–related mortality in men, according to findings fr...

The ASCO Post

May 15, 2026

Early Ovarian Cancer: Minimally Invasive Surgery, Intraoperative Capsule Rupture, and Survival

In a retrospective cohort study reported as a research letter in JAMA Oncology, Matsuo et al found an increasing use of minimally invasive surgery (MIS), an association of MIS with intraoperative caps...

The ASCO Post

May 15, 2026

Local Salvage Therapy for Post-Radiotherapy Local Recurrence of Prostate Cancer

In a systematic review and meta-analysis reported in JAMA Oncology, Miszczyk et al found that local therapies alone are associated with “reasonable efficacy” in select patients with locally radiorecur...

The ASCO Post

May 15, 2026

Could AI Be Licensed to Practice Oncology?

Is artificial intelligence (AI) poised to practice medicine? It may be already. Earlier this year, the state of Utah allowed Doctronic, a health technology company using AI to make clinical decisions ...

The ASCO Post

May 15, 2026

Study Finds DLBCL Subtype May Have Higher Mortality Risk in Female Patients

By analyzing data from nearly 5,000 patients across 14 independent studies, a research team found that women who carry simultaneous faults in two genes called SPEN and NOTCH2 had a more than fourfold ...

The ASCO Post

May 15, 2026

Relacorilant Plus Nab-Paclitaxel Improves Overall Survival in Platinum-Resistant Ovarian Cancer

Final overall survival results from the phase III ROSELLA trial showed a statistically and clinically significant survival benefit with the selective glucocorticoid receptor antagonist relacorilant pl...

The ASCO Post